| pubmed-article:7954642 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7954642 | lifeskim:mentions | umls-concept:C0034493 | lld:lifeskim |
| pubmed-article:7954642 | lifeskim:mentions | umls-concept:C0027061 | lld:lifeskim |
| pubmed-article:7954642 | lifeskim:mentions | umls-concept:C0278134 | lld:lifeskim |
| pubmed-article:7954642 | lifeskim:mentions | umls-concept:C1955862 | lld:lifeskim |
| pubmed-article:7954642 | lifeskim:mentions | umls-concept:C0231491 | lld:lifeskim |
| pubmed-article:7954642 | lifeskim:mentions | umls-concept:C0599946 | lld:lifeskim |
| pubmed-article:7954642 | lifeskim:mentions | umls-concept:C0023636 | lld:lifeskim |
| pubmed-article:7954642 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:7954642 | pubmed:dateCreated | 1994-12-29 | lld:pubmed |
| pubmed-article:7954642 | pubmed:abstractText | ATP sensitive potassium (KATP) channels have been implicated in the mechanism of ischaemic preconditioning, though apparently not in the pentobarbitone anaesthetised rabbit model. The aim of this study was to test whether potassium channel activation and blockade would alter protection in ketamine-xylazine anaesthetised rabbits. | lld:pubmed |
| pubmed-article:7954642 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7954642 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7954642 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7954642 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7954642 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7954642 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7954642 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7954642 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7954642 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7954642 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7954642 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7954642 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7954642 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7954642 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7954642 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7954642 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7954642 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:7954642 | pubmed:issn | 0008-6363 | lld:pubmed |
| pubmed-article:7954642 | pubmed:author | pubmed-author:DownerJ DJD | lld:pubmed |
| pubmed-article:7954642 | pubmed:author | pubmed-author:DalyJ JJJ | lld:pubmed |
| pubmed-article:7954642 | pubmed:author | pubmed-author:CohenM VMV | lld:pubmed |
| pubmed-article:7954642 | pubmed:author | pubmed-author:TsuchidaAA | lld:pubmed |
| pubmed-article:7954642 | pubmed:author | pubmed-author:ThorntonJ DJD | lld:pubmed |
| pubmed-article:7954642 | pubmed:author | pubmed-author:WalshR SRS | lld:pubmed |
| pubmed-article:7954642 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7954642 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:7954642 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7954642 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7954642 | pubmed:pagination | 1337-41 | lld:pubmed |
| pubmed-article:7954642 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:7954642 | pubmed:meshHeading | pubmed-meshheading:7954642-... | lld:pubmed |
| pubmed-article:7954642 | pubmed:meshHeading | pubmed-meshheading:7954642-... | lld:pubmed |
| pubmed-article:7954642 | pubmed:meshHeading | pubmed-meshheading:7954642-... | lld:pubmed |
| pubmed-article:7954642 | pubmed:meshHeading | pubmed-meshheading:7954642-... | lld:pubmed |
| pubmed-article:7954642 | pubmed:meshHeading | pubmed-meshheading:7954642-... | lld:pubmed |
| pubmed-article:7954642 | pubmed:meshHeading | pubmed-meshheading:7954642-... | lld:pubmed |
| pubmed-article:7954642 | pubmed:meshHeading | pubmed-meshheading:7954642-... | lld:pubmed |
| pubmed-article:7954642 | pubmed:meshHeading | pubmed-meshheading:7954642-... | lld:pubmed |
| pubmed-article:7954642 | pubmed:meshHeading | pubmed-meshheading:7954642-... | lld:pubmed |
| pubmed-article:7954642 | pubmed:meshHeading | pubmed-meshheading:7954642-... | lld:pubmed |
| pubmed-article:7954642 | pubmed:meshHeading | pubmed-meshheading:7954642-... | lld:pubmed |
| pubmed-article:7954642 | pubmed:meshHeading | pubmed-meshheading:7954642-... | lld:pubmed |
| pubmed-article:7954642 | pubmed:meshHeading | pubmed-meshheading:7954642-... | lld:pubmed |
| pubmed-article:7954642 | pubmed:meshHeading | pubmed-meshheading:7954642-... | lld:pubmed |
| pubmed-article:7954642 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7954642 | pubmed:articleTitle | Ketamine-xylazine anaesthesia permits a KATP channel antagonist to attenuate preconditioning in rabbit myocardium. | lld:pubmed |
| pubmed-article:7954642 | pubmed:affiliation | University of South Alabama, College of Medicine, Mobile 36688. | lld:pubmed |
| pubmed-article:7954642 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7954642 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:7954642 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7954642 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7954642 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7954642 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7954642 | lld:pubmed |
